vs

Side-by-side financial comparison of GULFPORT ENERGY CORP (GPOR) and SelectQuote, Inc. (SLQT). Click either name above to swap in a different company.

SelectQuote, Inc. is the larger business by last-quarter revenue ($537.1M vs $398.2M, roughly 1.3× GULFPORT ENERGY CORP). GULFPORT ENERGY CORP runs the higher net margin — 33.3% vs 12.9%, a 20.4% gap on every dollar of revenue. On growth, GULFPORT ENERGY CORP posted the faster year-over-year revenue change (66.0% vs 11.6%). Over the past eight quarters, SelectQuote, Inc.'s revenue compounded faster (19.5% CAGR vs 18.6%).

Gulfport Energy Corp is a U.S.-headquartered independent oil and natural gas exploration and production company. It primarily operates in onshore resource basins including Ohio's Utica Shale and Oklahoma's SCOOP play, producing natural gas, crude oil, and natural gas liquids to supply North American industrial, utility, and commercial end markets.

SelectQuote is a direct-to-consumer distribution platform for selling insurance policies and healthcare services. Their insurance business earns commissions by connecting consumers with insurance carriers that provide senior health, life, automobile, and home insurance. The healthcare services business mainly consists of SelectRx, an accredited pharmacy. The company went public on May 21, 2020.

GPOR vs SLQT — Head-to-Head

Bigger by revenue
SLQT
SLQT
1.3× larger
SLQT
$537.1M
$398.2M
GPOR
Growing faster (revenue YoY)
GPOR
GPOR
+54.4% gap
GPOR
66.0%
11.6%
SLQT
Higher net margin
GPOR
GPOR
20.4% more per $
GPOR
33.3%
12.9%
SLQT
Faster 2-yr revenue CAGR
SLQT
SLQT
Annualised
SLQT
19.5%
18.6%
GPOR

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
GPOR
GPOR
SLQT
SLQT
Revenue
$398.2M
$537.1M
Net Profit
$132.4M
$69.3M
Gross Margin
76.6%
61.8%
Operating Margin
44.9%
14.0%
Net Margin
33.3%
12.9%
Revenue YoY
66.0%
11.6%
Net Profit YoY
148.5%
30.2%
EPS (diluted)
$7.98
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GPOR
GPOR
SLQT
SLQT
Q4 25
$398.2M
$537.1M
Q3 25
$379.7M
$328.8M
Q2 25
$447.6M
$345.1M
Q1 25
$197.0M
$408.2M
Q4 24
$239.9M
$481.1M
Q3 24
$253.9M
$292.3M
Q2 24
$181.1M
$307.2M
Q1 24
$283.2M
$376.4M
Net Profit
GPOR
GPOR
SLQT
SLQT
Q4 25
$132.4M
$69.3M
Q3 25
$111.4M
$-30.5M
Q2 25
$184.5M
$12.9M
Q1 25
$-464.0K
$26.0M
Q4 24
$-273.2M
$53.2M
Q3 24
$-14.0M
$-44.5M
Q2 24
$-26.2M
$-31.0M
Q1 24
$52.0M
$8.6M
Gross Margin
GPOR
GPOR
SLQT
SLQT
Q4 25
76.6%
61.8%
Q3 25
74.6%
41.4%
Q2 25
80.7%
47.2%
Q1 25
57.9%
60.2%
Q4 24
63.2%
67.5%
Q3 24
64.6%
55.7%
Q2 24
52.2%
60.7%
Q1 24
69.4%
71.8%
Operating Margin
GPOR
GPOR
SLQT
SLQT
Q4 25
44.9%
14.0%
Q3 25
41.9%
-12.4%
Q2 25
56.0%
-3.6%
Q1 25
6.1%
5.4%
Q4 24
-131.3%
14.7%
Q3 24
5.7%
-4.1%
Q2 24
-10.0%
-0.5%
Q1 24
28.9%
8.8%
Net Margin
GPOR
GPOR
SLQT
SLQT
Q4 25
33.3%
12.9%
Q3 25
29.3%
-9.3%
Q2 25
41.2%
3.7%
Q1 25
-0.2%
6.4%
Q4 24
-113.9%
11.1%
Q3 24
-5.5%
-15.2%
Q2 24
-14.5%
-10.1%
Q1 24
18.4%
2.3%
EPS (diluted)
GPOR
GPOR
SLQT
SLQT
Q4 25
$7.98
$0.26
Q3 25
$4.45
$-0.26
Q2 25
$9.12
$-0.06
Q1 25
$-0.07
$0.03
Q4 24
$-14.72
$0.30
Q3 24
$-0.83
$-0.26
Q2 24
$-1.51
$-0.17
Q1 24
$2.34
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GPOR
GPOR
SLQT
SLQT
Cash + ST InvestmentsLiquidity on hand
$1.8M
$18.3M
Total DebtLower is stronger
$788.2M
$405.8M
Stockholders' EquityBook value
$1.8B
$359.7M
Total Assets
$3.0B
$1.4B
Debt / EquityLower = less leverage
0.43×
1.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GPOR
GPOR
SLQT
SLQT
Q4 25
$1.8M
$18.3M
Q3 25
$3.4M
$10.7M
Q2 25
$3.8M
$32.4M
Q1 25
$5.3M
$80.1M
Q4 24
$1.5M
$7.3M
Q3 24
$3.2M
$10.4M
Q2 24
$1.2M
$42.7M
Q1 24
$8.2M
$37.8M
Total Debt
GPOR
GPOR
SLQT
SLQT
Q4 25
$788.2M
$405.8M
Q3 25
$691.7M
$393.1M
Q2 25
$695.2M
$385.1M
Q1 25
$700.4M
$391.5M
Q4 24
$702.9M
$711.9M
Q3 24
$694.4M
$680.4M
Q2 24
$679.5M
$683.3M
Q1 24
$636.4M
$686.0M
Stockholders' Equity
GPOR
GPOR
SLQT
SLQT
Q4 25
$1.8B
$359.7M
Q3 25
$1.8B
$305.1M
Q2 25
$1.8B
$351.1M
Q1 25
$1.7B
$350.2M
Q4 24
$1.7B
$326.0M
Q3 24
$2.1B
$269.4M
Q2 24
$2.1B
$316.8M
Q1 24
$2.2B
$346.8M
Total Assets
GPOR
GPOR
SLQT
SLQT
Q4 25
$3.0B
$1.4B
Q3 25
$2.9B
$1.2B
Q2 25
$3.0B
$1.2B
Q1 25
$2.9B
$1.3B
Q4 24
$2.9B
$1.3B
Q3 24
$3.2B
$1.1B
Q2 24
$3.2B
$1.2B
Q1 24
$3.3B
$1.2B
Debt / Equity
GPOR
GPOR
SLQT
SLQT
Q4 25
0.43×
1.13×
Q3 25
0.38×
1.29×
Q2 25
0.39×
1.10×
Q1 25
0.42×
1.12×
Q4 24
0.41×
2.18×
Q3 24
0.34×
2.53×
Q2 24
0.32×
2.16×
Q1 24
0.29×
1.98×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GPOR
GPOR
SLQT
SLQT
Operating Cash FlowLast quarter
$185.4M
$52.0K
Free Cash FlowOCF − Capex
$-1.0M
FCF MarginFCF / Revenue
-0.2%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
1.40×
0.00×
TTM Free Cash FlowTrailing 4 quarters
$8.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GPOR
GPOR
SLQT
SLQT
Q4 25
$185.4M
$52.0K
Q3 25
$209.1M
$-21.6M
Q2 25
$231.4M
$-37.5M
Q1 25
$177.3M
$71.1M
Q4 24
$148.8M
$-28.7M
Q3 24
$189.7M
$-16.6M
Q2 24
$123.5M
$20.0M
Q1 24
$188.0M
$44.5M
Free Cash Flow
GPOR
GPOR
SLQT
SLQT
Q4 25
$-1.0M
Q3 25
$-22.7M
Q2 25
$-38.0M
Q1 25
$70.2M
Q4 24
$-29.0M
Q3 24
$-17.1M
Q2 24
$19.7M
Q1 24
$43.4M
FCF Margin
GPOR
GPOR
SLQT
SLQT
Q4 25
-0.2%
Q3 25
-6.9%
Q2 25
-11.0%
Q1 25
17.2%
Q4 24
-6.0%
Q3 24
-5.8%
Q2 24
6.4%
Q1 24
11.5%
Capex Intensity
GPOR
GPOR
SLQT
SLQT
Q4 25
0.2%
Q3 25
0.3%
Q2 25
0.1%
Q1 25
0.2%
Q4 24
0.1%
Q3 24
0.2%
Q2 24
0.1%
Q1 24
0.3%
Cash Conversion
GPOR
GPOR
SLQT
SLQT
Q4 25
1.40×
0.00×
Q3 25
1.88×
Q2 25
1.25×
-2.91×
Q1 25
2.73×
Q4 24
-0.54×
Q3 24
Q2 24
Q1 24
3.61×
5.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GPOR
GPOR

Natural Gas Production$296.9M75%
Other$42.7M11%
Naturalgasliquidsales$35.2M9%
Oil And Condensate$23.4M6%

SLQT
SLQT

Healthcare Services Segment$230.7M43%
Pharmacy$227.2M42%
Other$30.4M6%
Final Expense$20.4M4%
Term$18.5M3%
Other Senior$6.3M1%
All Other Revenue$3.9M1%

Related Comparisons